CD274 (Hou et al., 2020a) is a key molecule of tumor immune checkpoint mechanisms, is one of the main targets of immunotherapy (Fabrizio et al., 2018), and plays an important role in tumor immune escape (Huang et al., 2019). Here, CD274 is linked to neoplasm.